JP2015514072A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514072A5
JP2015514072A5 JP2015501784A JP2015501784A JP2015514072A5 JP 2015514072 A5 JP2015514072 A5 JP 2015514072A5 JP 2015501784 A JP2015501784 A JP 2015501784A JP 2015501784 A JP2015501784 A JP 2015501784A JP 2015514072 A5 JP2015514072 A5 JP 2015514072A5
Authority
JP
Japan
Prior art keywords
fluoro
phenyl
indazol
acrylic acid
vinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015501784A
Other languages
English (en)
Japanese (ja)
Other versions
JP6154887B2 (ja
JP2015514072A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/031507 external-priority patent/WO2013142266A1/en
Publication of JP2015514072A publication Critical patent/JP2015514072A/ja
Publication of JP2015514072A5 publication Critical patent/JP2015514072A5/ja
Application granted granted Critical
Publication of JP6154887B2 publication Critical patent/JP6154887B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015501784A 2012-03-20 2013-03-14 エストロゲン受容体モジュレーターおよびその使用 Active JP6154887B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261613442P 2012-03-20 2012-03-20
US61/613,442 2012-03-20
PCT/US2013/031507 WO2013142266A1 (en) 2012-03-20 2013-03-14 Estrogen receptor modulators and uses thereof

Publications (3)

Publication Number Publication Date
JP2015514072A JP2015514072A (ja) 2015-05-18
JP2015514072A5 true JP2015514072A5 (enExample) 2017-02-09
JP6154887B2 JP6154887B2 (ja) 2017-06-28

Family

ID=49223229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501784A Active JP6154887B2 (ja) 2012-03-20 2013-03-14 エストロゲン受容体モジュレーターおよびその使用

Country Status (17)

Country Link
US (1) US9499538B2 (enExample)
EP (1) EP2828243B1 (enExample)
JP (1) JP6154887B2 (enExample)
KR (1) KR20140138296A (enExample)
CN (1) CN104220426B (enExample)
AU (1) AU2013235499A1 (enExample)
CA (1) CA2866891A1 (enExample)
CO (1) CO7170179A2 (enExample)
CR (1) CR20140479A (enExample)
EA (1) EA201491530A1 (enExample)
IL (1) IL234487A0 (enExample)
MX (1) MX2014011217A (enExample)
NZ (1) NZ630124A (enExample)
PE (1) PE20142461A1 (enExample)
PH (1) PH12014502095A1 (enExample)
SG (1) SG11201405918XA (enExample)
WO (1) WO2013142266A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201491530A1 (ru) 2012-03-20 2015-07-30 Серагон Фармасьютикалс, Инк. Модуляторы рецепторов эстрогенов и их применение
JP2016517420A (ja) 2013-03-14 2016-06-16 セラゴン ファーマシューティカルズ, インク. 多環式エストロゲン受容体モジュレーター及びその使用
US10000459B2 (en) 2013-03-15 2018-06-19 Epigen Biosciences, Inc. Heterocyclic compounds useful in the treatment of disease
WO2014205136A1 (en) 2013-06-19 2014-12-24 Seragon Pharmaceuticals, Inc. Azetidine estrogen receptor modulators and uses thereof
BR112015031903A8 (pt) 2013-06-19 2019-12-31 Seragon Pharmaceuticals Inc composto, sal farmaceuticamente aceitável, composição farmacêutica e uso de um composto
EP3089747A1 (en) 2013-12-06 2016-11-09 F. Hoffmann-La Roche AG Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer
JP2017507964A (ja) 2014-03-13 2017-03-23 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト エストロゲン受容体モジュレーターを用いた治療的組合せ
AU2015228860A1 (en) * 2014-03-13 2016-09-08 F. Hoffmann-La Roche Ag Methods and compositions for modulating estrogen receptor mutants
US9783503B2 (en) 2014-08-11 2017-10-10 Genentech, Inc. Crystalline forms of an estrogen receptor modulator
CN107531722B (zh) 2015-05-26 2020-07-17 豪夫迈·罗氏有限公司 杂环雌激素受体调节剂及其用途
PL3302471T3 (pl) 2015-05-29 2022-02-07 Eisai R&D Management Co., Ltd. Tetrapodstawione związki alkenowe i ich zastosowanie
CN105061316B (zh) * 2015-07-17 2017-12-22 苏州大学 稠环类化合物、制备方法和用途
CN106518768B (zh) * 2015-09-15 2021-07-02 江苏恒瑞医药股份有限公司 丙烯酸类衍生物、其制备方法及其在医药上的应用
EP3359527A1 (en) 2015-10-07 2018-08-15 H. Hoffnabb-La Roche Ag Process for the preparation of (e)-3-(4-((e)-2-(2-chloro-4-fluorophenyl)-1-(1h-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
NZ743651A (en) 2015-12-09 2023-07-28 Univ Illinois Benzothiophene-based selective estrogen receptor downregulators
CA3018801C (en) * 2016-03-25 2020-06-23 Luoxin Biotechnology (Shanghai) Co., Ltd Substituted-indole compounds as estrogen receptor down-regulators
CA3017388C (en) 2016-04-01 2024-03-12 Zeno Royalties & Milestones, LLC Estrogen receptor modulators
HUE057289T2 (hu) 2016-08-31 2022-05-28 Jiangsu Hengrui Medicine Co Oxopikolinamid-származék, annak elõállítási módszere és gyógyszerészeti felhasználása
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
WO2018098305A1 (en) * 2016-11-24 2018-05-31 Eisai R&D Management Co., Ltd. Tetrasubstituted alkene compounds and their use for the treatment of breast cancer
EP3544967B1 (en) 2016-11-28 2023-06-28 Eisai R&D Management Co., Ltd. Salts of indazole derivative and crystals thereof
TWI823845B (zh) 2017-01-06 2023-12-01 美商G1治療公司 用於治療癌症的組合療法
WO2018148576A1 (en) 2017-02-10 2018-08-16 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators
CN108976187B (zh) * 2017-06-02 2021-11-26 上海青东生物科技有限公司 一种取代苯并呋喃衍生物及其制备与在制备抗肿瘤药物中的应用
WO2019225552A1 (en) * 2018-05-22 2019-11-28 Eisai R&D Management Co., Ltd. Salts of indazole derivative and crystals thereof
KR102754524B1 (ko) 2018-08-17 2025-01-13 제넨테크, 인크. 유방암 치료를 위한 진단 및 치료 방법들
MX2021007088A (es) * 2018-12-17 2021-09-08 Chia Tai Tianqing Pharmaceutical Group Co Ltd Antagonista del receptor de estrogeno.
KR20220024476A (ko) * 2019-06-19 2022-03-03 지앙수 헨그루이 메디슨 컴퍼니 리미티드 인다졸 유도체, 이의 제조 방법, 및 이의 약제학적 적용
US11278532B2 (en) 2019-08-06 2022-03-22 Recurium Ip Holdings, Llc Estrogen receptor modulators for treating mutants
JP2024502270A (ja) 2020-12-23 2024-01-18 リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー エストロゲン受容体調節薬
CN115745895A (zh) * 2021-11-13 2023-03-07 温州奥洋科技有限公司 一种紫外线吸收剂二苯嘧啶乙烯的结构与合成路线
CN116239562B (zh) * 2021-12-07 2024-12-31 江苏师范大学 一种以苯并呋喃酮为原料合成盐酸多塞平的方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002097B1 (en) * 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
US4229447A (en) 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
US4596795A (en) 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
JPH0778017B2 (ja) 1985-12-28 1995-08-23 住友製薬株式会社 パルス的かつ持続放出性製剤
US4755386A (en) 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5739136A (en) 1989-10-17 1998-04-14 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering medicaments
US5017381A (en) 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
US5229135A (en) 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
JP3409366B2 (ja) 1993-06-18 2003-05-26 東洋インキ製造株式会社 有機エレクトロルミネッセンス素子
US5681835A (en) 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
DE19807760A1 (de) 1997-02-27 1998-09-03 Fuji Electric Co Ltd Elektrofotografischer Fotoleiter
US5840329A (en) 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
CZ300929B6 (cs) 1997-08-15 2009-09-16 Duke University Sloucenina pro použití pri lécení nebo prevenci estrogenem stimulované rakoviny
DE19801597C2 (de) 1998-01-17 2001-05-03 Aventis Res & Tech Gmbh & Co Basenkatalysierte Synthese von 1-Aryl-4-(arylethyl)piperazinen aus aromatischen Olefinen und 1-Arylpiperazinen
DE19801598C2 (de) 1998-01-17 2000-05-11 Aventis Res & Tech Gmbh & Co Katalytische Synthese von N-alkylierten Anilinen aus Olefinen und Anilinen
TW593256B (en) 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
GB9929988D0 (en) 1999-12-17 2000-02-09 Celltech Therapeutics Ltd Chemical compounds
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
AU2002323098A1 (en) 2001-08-11 2003-03-03 Bristol-Myers Squibb Pharma Company Selective estrogen receptor modulators
US7414040B2 (en) 2002-06-06 2008-08-19 Smithkline Beecham Corporation Thrombopoietin mimetics
ATE399775T1 (de) * 2003-10-08 2008-07-15 Smithkline Beecham Corp Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors
DE102004028862A1 (de) * 2004-06-15 2005-12-29 Merck Patent Gmbh 3-Aminoindazole
US20070292545A1 (en) 2005-10-18 2007-12-20 Aaron Monte Anti-infective agents and methods of use
CN101146796A (zh) * 2005-01-26 2008-03-19 先灵公司 作为蛋白激酶抑制剂用于治疗癌症的3-(吲唑-5-基)-(1,2,4)三嗪衍生物及相关化合物
JP2009504872A (ja) 2005-08-15 2009-02-05 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド 印刷可能な材料
JP2010508358A (ja) 2006-11-01 2010-03-18 ブリストル−マイヤーズ スクイブ カンパニー グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用
JP2008156313A (ja) 2006-12-26 2008-07-10 Fyuuensu:Kk アミロイド疾患の治療およびモニタリングのための薬剤
GB0704407D0 (en) 2007-03-07 2007-04-18 Glaxo Group Ltd Compounds
DE102007049451A1 (de) * 2007-10-16 2009-04-23 Merck Patent Gmbh 5-Cyano-thienopyridine
JP5223362B2 (ja) 2008-02-07 2013-06-26 コニカミノルタビジネステクノロジーズ株式会社 光電変換素子及び太陽電池
WO2009131654A2 (en) 2008-04-21 2009-10-29 North Carolina State University Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
US8697685B2 (en) 2008-11-20 2014-04-15 Glaxosmithkline Llc Chemical compounds
WO2010077603A1 (en) 2008-12-08 2010-07-08 North Carolina State University Inhibition and dispersion of biofilms in plants with imidazole-triazole derivatives
WO2010107474A1 (en) 2009-03-16 2010-09-23 The Research Foundation Of State University Of New York Antiestrogens for breast cancer therapy
WO2010144959A1 (en) 2009-06-18 2010-12-23 Fibrotech Therapeutics Pty Ltd Analogues of anti-fibrotic agents
GB2483736B (en) 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
EA201491530A1 (ru) 2012-03-20 2015-07-30 Серагон Фармасьютикалс, Инк. Модуляторы рецепторов эстрогенов и их применение
JP6126562B2 (ja) * 2014-08-27 2017-05-10 三星ダイヤモンド工業株式会社 光ファイバ装置

Similar Documents

Publication Publication Date Title
JP2015514072A5 (enExample)
RU2015138964A (ru) Полициклические модуляторы рецептора эстрогена и их применения
JP2014531465A5 (enExample)
JP2014528446A5 (enExample)
RU2015132181A (ru) Фтор-[1,3]-оксазины в качестве ингибиторов васе1
JP2014518214A5 (enExample)
HRP20160539T1 (hr) Antagonisti trpv4
JP2016512259A5 (enExample)
JP2014525444A5 (enExample)
RU2021129721A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2017528519A5 (enExample)
JP2009541311A5 (enExample)
JP2012508223A5 (enExample)
JP2018535999A5 (enExample)
EA018721B1 (ru) Модуляторы сигнального пути hedgehog
RU2012133475A (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
JP2017500364A5 (enExample)
JP2020536116A5 (enExample)
JP2020529419A5 (enExample)
JP2020510046A5 (enExample)
JP2020503293A5 (enExample)
JP2019508400A5 (enExample)
JPWO2021124172A5 (enExample)
JP7554492B2 (ja) フェニルイミダゾール化合物
JPWO2023009663A5 (enExample)